Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Gaucher disease: when molecular testing and clinical presentation disagree -the novel c.1226A>G(p.N370S)--RecNcil allele.

Balwani M, Grace ME, Desnick RJ.

J Inherit Metab Dis. 2011 Jun;34(3):789-93. doi: 10.1007/s10545-011-9307-7. Epub 2011 Mar 23.

2.

Frequency of unrecognized Fabry disease among young European-American and African-American men with first ischemic stroke.

Wozniak MA, Kittner SJ, Tuhrim S, Cole JW, Stern B, Dobbins M, Grace ME, Nazarenko I, Dobrovolny R, McDade E, Desnick RJ.

Stroke. 2010 Jan;41(1):78-81. doi: 10.1161/STROKEAHA.109.558320. Epub 2009 Dec 10.

3.

Type 1 Gaucher disease: null and hypomorphic novel chitotriosidase mutations-implications for diagnosis and therapeutic monitoring.

Grace ME, Balwani M, Nazarenko I, Prakash-Cheng A, Desnick RJ.

Hum Mutat. 2007 Sep;28(9):866-73.

PMID:
17464953
4.

Bladder neck mobility is a heritable trait.

Dietz HP, Hansell NK, Grace ME, Eldridge AM, Clarke B, Martin NG.

BJOG. 2005 Mar;112(3):334-9.

5.

Pulmonary hypertension in type 1 Gaucher's disease: genetic and epigenetic determinants of phenotype and response to therapy.

Mistry PK, Sirrs S, Chan A, Pritzker MR, Duffy TP, Grace ME, Meeker DP, Goldman ME.

Mol Genet Metab. 2002 Sep-Oct;77(1-2):91-8.

PMID:
12359135
6.

Gaucher disease: expression and characterization of mild and severe acid beta-glucosidase mutations in Portuguese type 1 patients.

Amaral O, Marcão A, Sá Miranda M, Desnick RJ, Grace ME.

Eur J Hum Genet. 2000 Feb;8(2):95-102.

7.

Myoclonus from selective dentate nucleus degeneration in type 3 Gaucher disease.

Verghese J, Goldberg RF, Desnick RJ, Grace ME, Goldman JE, Lee SC, Dickson DW, Rapin I.

Arch Neurol. 2000 Mar;57(3):389-95.

PMID:
10714667
8.

Type 1 Gaucher disease presenting with extensive mandibular lytic lesions: identification and expression of a novel acid beta-glucosidase mutation.

Wasserstein MP, Martignetti JA, Zeitlin R, Lumerman H, Solomon M, Grace ME, Desnick RJ.

Am J Med Genet. 1999 Jun 4;84(4):334-9.

PMID:
10340647
9.

Non-pseudogene-derived complex acid beta-glucosidase mutations causing mild type 1 and severe type 2 gaucher disease.

Grace ME, Ashton-Prolla P, Pastores GM, Soni A, Desnick RJ.

J Clin Invest. 1999 Mar;103(6):817-23.

10.

Human alpha-galactosidase A: glycosylation site 3 is essential for enzyme solubility.

Ioannou YA, Zeidner KM, Grace ME, Desnick RJ.

Biochem J. 1998 Jun 15;332 ( Pt 3):789-97.

12.

Identification of Glu340 as the active-site nucleophile in human glucocerebrosidase by use of electrospray tandem mass spectrometry.

Miao S, McCarter JD, Grace ME, Grabowski GA, Aebersold R, Withers SG.

J Biol Chem. 1994 Apr 15;269(15):10975-8.

13.

Analysis of human acid beta-glucosidase by site-directed mutagenesis and heterologous expression.

Grace ME, Newman KM, Scheinker V, Berg-Fussman A, Grabowski GA.

J Biol Chem. 1994 Jan 21;269(3):2283-91.

14.

Human acid beta-glucosidase. N-glycosylation site occupancy and the effect of glycosylation on enzymatic activity.

Berg-Fussman A, Grace ME, Ioannou Y, Grabowski GA.

J Biol Chem. 1993 Jul 15;268(20):14861-6.

15.

Enzyme augmentation in moderate to life-threatening Gaucher disease.

Fallet S, Grace ME, Sibille A, Mendelson DS, Shapiro RS, Hermann G, Grabowski GA.

Pediatr Res. 1992 May;31(5):496-502.

PMID:
1603627
16.

Gaucher disease: four rare alleles encoding F213I, P289L, T323I, and R463C in type 1 variants.

He GS, Grace ME, Grabowski GA.

Hum Mutat. 1992;1(5):423-7. No abstract available.

PMID:
1301953
17.

The disposition and metabolism of [14C]piritrexim in dogs after intravenous and oral administration.

Woolley JL, Deangelis DV, Grace ME, Liao SH, Crouch RC, Sigel CW.

Drug Metab Dispos. 1991 Nov-Dec;19(6):1139-46.

PMID:
1687022
18.

Gaucher disease: heterologous expression of two alleles associated with neuronopathic phenotypes.

Grace ME, Berg A, He GS, Goldberg L, Horowitz M, Grabowski GA.

Am J Hum Genet. 1991 Sep;49(3):646-55.

19.

Human acid beta-glucosidase: glycosylation is required for catalytic activity.

Grace ME, Grabowski GA.

Biochem Biophys Res Commun. 1990 Apr 30;168(2):771-7.

PMID:
2110456
21.

Expression of functional human acid beta-glucosidase in COS-1 and Spodoptera frugiperda cells.

Grabowski GA, White WR, Grace ME.

Enzyme. 1989;41(3):131-42.

PMID:
2498077
22.

Elimination of antibiotic-resistant plasmids by quinolone antibiotics.

Fu KP, Grace ME, Hsiao CL, Hung PP.

Chemotherapy. 1988;34(5):415-8.

PMID:
3141117
23.

2,4-Diamino-5-benzylpyrimidines and analogues as antibacterial agents. 9. Lipophilic trimethoprim analogues as antigonococcal agents.

Roth B, Baccanari DP, Sigel CW, Hubbell JP, Eaddy J, Kao JC, Grace ME, Rauckman BS.

J Med Chem. 1988 Jan;31(1):122-9.

PMID:
3121854
24.
25.

Interaction of clavulanic acid, sulbactam and cephamycin antibiotics with beta-lactamases.

Grace ME, Fu KP, Gregory FJ, Hung PP.

Drugs Exp Clin Res. 1987;13(3):145-8.

PMID:
3040368
26.

Purification and properties of a beta-lactamase from Proteus penneri.

Grace ME, Gregory FJ, Hung PP, Fu KP.

J Antibiot (Tokyo). 1986 Jul;39(7):938-42.

27.

Discrepancy between the antibacterial activities and the inhibitory effects on Micrococcus luteus DNA gyrase of 13 quinolones.

Fu KP, Grace ME, McCloud SJ, Gregory FJ, Hung PP.

Chemotherapy. 1986;32(6):494-8.

PMID:
3026740
28.

Trimethoprim and sulfadiazine concentrations in aqueous and vitreous humors of the dog.

Sigel CW, Macklin AW, Grace ME, Tracy CH.

Vet Med Small Anim Clin. 1981 Jul;76(7):991-3. No abstract available.

PMID:
6975528
29.

Diffusion of trimethoprim and sulfamethoxazole from susceptibility disks into agar medium.

Grace ME, Bushby SR, Sigel CW.

Antimicrob Agents Chemother. 1975 Jul;8(1):45-9.

30.

Specific TLC determination of trimethoprim and sulfamethoxazole in plasma.

Sigel CW, Grace ME, Nichol CA, Hitchings GH.

J Pharm Sci. 1974 Aug;63(8):1212-5. No abstract available.

PMID:
4854354
31.

Metabolism of trimethoprim in man and measurement of a new metabolite: a new fluorescence assay.

Sigel CW, Grace ME, Nichol CA.

J Infect Dis. 1973 Nov;128:Suppl:580-3 p. No abstract available.

PMID:
4758049
32.

A new fluorescence assay of trimethoprim and metabolites using quantitative thin-layer chromatography.

Sigel CW, Grace ME.

J Chromatogr. 1973 May 30;80(1):111-6. No abstract available.

PMID:
4708398
33.

Metabolic fates of N-methyl- -phenylsuccinimide (phensuximide, milontin) and of -phenylsuccinimide in the dog.

Dudley KH, Bius DL, Grace ME.

J Pharmacol Exp Ther. 1972 Jan;180(1):167-79. No abstract available.

PMID:
5010412

Supplemental Content

Loading ...
Support Center